MedTrace Logo

Decision Aids to Improve Knowledge in Patients With Prostate Cancer

NCT03182998 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2023-08-02

Study results available
· View outcomes & findings →

Summary

This randomized phase III trial studies how well decision aids work in improving knowledge in patients with prostate cancer. Decision aids may improve patients' knowledge of their condition and options for treatment, and may also help when talking with their doctor.

Conditions

Interventions

OTHER

Internet-Based Intervention

Receive "Knowing your Options" decision aid

OTHER

Internet-Based Intervention

Receive "Prostate Choice" decision aid

OTHER

Best Practice

Undergo usual care

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Survey Administration

Ancillary studies

OTHER

Laboratory Biomarker Analysis

Correlative studies

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Jon C. Tilburt, M.D. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-14
Primary Completion
2022-02-04
Completion
2022-02-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03182998 on ClinicalTrials.gov